Table 1. Chronic Hepatitis B Treatment Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Chronic Hepatitis B Treatment Market Restraints

Table 3. Chronic Hepatitis B Treatment Market Trends

Table 4. Chronic Hepatitis B Treatment Industry Policy

Table 5. Global Chronic Hepatitis B Treatment Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Chronic Hepatitis B Treatment Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Chronic Hepatitis B Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Chronic Hepatitis B Treatment Mergers & Acquisitions, Expansion Plans

Table 9. Global Chronic Hepatitis B Treatment Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China Chronic Hepatitis B Treatment Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 12. China Chronic Hepatitis B Treatment Revenue Market Share by Company, 2018-2023

Table 13. Global Key Players of Chronic Hepatitis B Treatment Upstream (Raw Materials)

Table 14. Global Chronic Hepatitis B Treatment Typical Customers

Table 15. Chronic Hepatitis B Treatment Typical Distributors

Table 16. By Type, Global Chronic Hepatitis B Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Application, Global Chronic Hepatitis B Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Chronic Hepatitis B Treatment Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 19. By Region, Global Chronic Hepatitis B Treatment Consumption Value, 2018-2029, US$ Million

Table 20. By Country, Global Chronic Hepatitis B Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 21. By Country, Global Chronic Hepatitis B Treatment Consumption Value, 2018-2029, US$ Million

Table 22. By Country, Global Chronic Hepatitis B Treatment Consumption Value Market Share, 2018-2029

Table 23. Novartis Company Information, Head Office, Market Area and Industry Position

Table 24. Novartis Company Profile and Main Business

Table 25. Novartis Chronic Hepatitis B Treatment Models, Specifications, and Application

Table 26. Novartis Chronic Hepatitis B Treatment Revenue and Gross Margin, US$ Million, 2018-2023

Table 27. Novartis Recent Developments

Table 28. ViiV Healthcare Company Information, Head Office, Market Area and Industry Position

Table 29. ViiV Healthcare Company Profile and Main Business

Table 30. ViiV Healthcare Chronic Hepatitis B Treatment Models, Specifications, and Application

Table 31. ViiV Healthcare Chronic Hepatitis B Treatment Revenue and Gross Margin, US$ Million, 2018-2023

Table 32. ViiV Healthcare Recent Developments

Table 33. Bristol-Myers Squibb Company Information, Head Office, Market Area and Industry Position

Table 34. Bristol-Myers Squibb Company Profile and Main Business

Table 35. Bristol-Myers Squibb Chronic Hepatitis B Treatment Models, Specifications, and Application

Table 36. Bristol-Myers Squibb Chronic Hepatitis B Treatment Revenue and Gross Margin, US$ Million, 2018-2023

Table 37. Bristol-Myers Squibb Recent Developments

Table 38. Gilead Sciences Company Information, Head Office, Market Area and Industry Position

Table 39. Gilead Sciences Company Profile and Main Business

Table 40. Gilead Sciences Chronic Hepatitis B Treatment Models, Specifications, and Application

Table 41. Gilead Sciences Chronic Hepatitis B Treatment Revenue and Gross Margin, US$ Million, 2018-2023

Table 42. Gilead Sciences Recent Developments

Table 43. Accord Healthcare Company Information, Head Office, Market Area and Industry Position

Table 44. Accord Healthcare Company Profile and Main Business

Table 45. Accord Healthcare Chronic Hepatitis B Treatment Models, Specifications, and Application

Table 46. Accord Healthcare Chronic Hepatitis B Treatment Revenue and Gross Margin, US$ Million, 2018-2023

Table 47. Accord Healthcare Recent Developments

Table 48. Teva Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 49. Teva Pharmaceuticals Company Profile and Main Business

Table 50. Teva Pharmaceuticals Chronic Hepatitis B Treatment Models, Specifications, and Application

Table 51. Teva Pharmaceuticals Chronic Hepatitis B Treatment Revenue and Gross Margin, US$ Million, 2018-2023

Table 52. Teva Pharmaceuticals Recent Developments

Table 53. Apotex Corp Company Information, Head Office, Market Area and Industry Position

Table 54. Apotex Corp Company Profile and Main Business

Table 55. Apotex Corp Chronic Hepatitis B Treatment Models, Specifications, and Application

Table 56. Apotex Corp Chronic Hepatitis B Treatment Revenue and Gross Margin, US$ Million, 2018-2023

Table 57. Apotex Corp Recent Developments

Table 58. CTTQ Company Information, Head Office, Market Area and Industry Position

Table 59. CTTQ Company Profile and Main Business

Table 60. CTTQ Chronic Hepatitis B Treatment Models, Specifications, and Application

Table 61. CTTQ Chronic Hepatitis B Treatment Revenue and Gross Margin, US$ Million, 2018-2023

Table 62. CTTQ Recent Developments

Table 63. Arbutus Biopharma Company Information, Head Office, Market Area and Industry Position

Table 64. Arbutus Biopharma Company Profile and Main Business

Table 65. Arbutus Biopharma Chronic Hepatitis B Treatment Models, Specifications, and Application

Table 66. Arbutus Biopharma Chronic Hepatitis B Treatment Revenue and Gross Margin, US$ Million, 2018-2023

Table 67. Arbutus Biopharma Recent Developments

Table 68. Lupin Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 69. Lupin Pharmaceuticals Company Profile and Main Business

Table 70. Lupin Pharmaceuticals Chronic Hepatitis B Treatment Models, Specifications, and Application

Table 71. Lupin Pharmaceuticals Chronic Hepatitis B Treatment Revenue and Gross Margin, US$ Million, 2018-2023

Table 72. Lupin Pharmaceuticals Recent Developments

List of Figures

Figure 1. Chronic Hepatitis B Treatment Picture

Figure 2. Global Chronic Hepatitis B Treatment Consumption Value, (US$ million) & (2018-2029)

Figure 3. China Chronic Hepatitis B Treatment Consumption Value, (US$ million) & (2018-2029)

Figure 4. By Consumption Value, China Chronic Hepatitis B Treatment Market Share of Global, 2018-2029

Figure 5. Global Chronic Hepatitis B Treatment Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 6. China Chronic Hepatitis B Treatment Key Participants, Market Share, 2022

Figure 7. Chronic Hepatitis B Treatment Industry Chain

Figure 8. Chronic Hepatitis B Treatment Procurement Model

Figure 9. Chronic Hepatitis B Treatment Sales Model

Figure 10. Chronic Hepatitis B Treatment Sales Channels, Direct Sales, and Distribution

Figure 11. Interferon

Figure 12. Antiviral Drugs

Figure 13. By Type, Global Chronic Hepatitis B Treatment Consumption Value, 2018-2029, US$ Million

Figure 14. By Type, Global Chronic Hepatitis B Treatment Consumption Value Market Share, 2018-2029

Figure 15. Hospitals

Figure 16. Homecare

Figure 17. Clinics

Figure 18. Others

Figure 19. By Application, Global Chronic Hepatitis B Treatment Consumption Value, 2018-2029, US$ Million

Figure 20. By Application, Global Chronic Hepatitis B Treatment Consumption Value Market Share, 2018-2029

Figure 21. By Region, Global Chronic Hepatitis B Treatment Consumption Value Market Share, 2018-2029

Figure 22. North America Chronic Hepatitis B Treatment Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 23. By Country, North America Chronic Hepatitis B Treatment Consumption Value Market Share, 2022

Figure 24. Europe Chronic Hepatitis B Treatment Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 25. By Country, Europe Chronic Hepatitis B Treatment Consumption Value Market Share, 2022

Figure 26. Asia Pacific Chronic Hepatitis B Treatment Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 27. By Country/Region, Asia Pacific Chronic Hepatitis B Treatment Consumption Value Market Share, 2022

Figure 28. South America Chronic Hepatitis B Treatment Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 29. By Country, South America Chronic Hepatitis B Treatment Consumption Value Market Share, 2022

Figure 30. Middle East & Africa Chronic Hepatitis B Treatment Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 31. U.S. Chronic Hepatitis B Treatment Consumption Value, 2018-2029, US$ Million

Figure 32. By Type, U.S. Chronic Hepatitis B Treatment Consumption Value Market Share, 2022 VS 2029

Figure 33. By Application, U.S. Chronic Hepatitis B Treatment Consumption Value Market Share, 2022 VS 2029

Figure 34. Europe Chronic Hepatitis B Treatment Consumption Value, 2018-2029, US$ Million

Figure 35. By Type, Europe Chronic Hepatitis B Treatment Consumption Value Market Share, 2022 VS 2029

Figure 36. By Application, Europe Chronic Hepatitis B Treatment Consumption Value Market Share, 2022 VS 2029

Figure 37. China Chronic Hepatitis B Treatment Consumption Value, 2018-2029, US$ Million

Figure 38. By Type, China Chronic Hepatitis B Treatment Consumption Value Market Share, 2022 VS 2029

Figure 39. By Application, China Chronic Hepatitis B Treatment Consumption Value Market Share, 2022 VS 2029

Figure 40. Japan Chronic Hepatitis B Treatment Consumption Value, 2018-2029, US$ Million

Figure 41. By Type, Japan Chronic Hepatitis B Treatment Consumption Value Market Share, 2022 VS 2029

Figure 42. By Application, Japan Chronic Hepatitis B Treatment Consumption Value Market Share, 2022 VS 2029

Figure 43. South Korea Chronic Hepatitis B Treatment Consumption Value, 2018-2029, US$ Million

Figure 44. By Type, South Korea Chronic Hepatitis B Treatment Consumption Value Market Share, 2022 VS 2029

Figure 45. By Application, South Korea Chronic Hepatitis B Treatment Consumption Value Market Share, 2022 VS 2029

Figure 46. Southeast Asia Chronic Hepatitis B Treatment Consumption Value, 2018-2029, US$ Million

Figure 47. By Type, Southeast Asia Chronic Hepatitis B Treatment Consumption Value Market Share, 2022 VS 2029

Figure 48. By Application, Southeast Asia Chronic Hepatitis B Treatment Consumption Value Market Share, 2022 VS 2029

Figure 49. India Chronic Hepatitis B Treatment Consumption Value, 2018-2029, US$ Million

Figure 50. By Type, India Chronic Hepatitis B Treatment Consumption Value Market Share, 2022 VS 2029

Figure 51. By Application, India Chronic Hepatitis B Treatment Consumption Value Market Share, 2022 VS 2029

Figure 52. Middle East & Africa Chronic Hepatitis B Treatment Consumption Value, 2018-2029, US$ Million

Figure 53. By Type, Middle East & Africa Chronic Hepatitis B Treatment Consumption Value Market Share, 2022 VS 2029

Figure 54. By Application, Middle East & Africa Chronic Hepatitis B Treatment Consumption Value Market Share, 2022 VS 2029

Figure 55. Research Methodology

Figure 56. Breakdown of Primary Interviews

Figure 57. Bottom-up and Top-down Approaches

Figure 58. Top-down Approaches